Social media, mobile applications and patient support programs are becoming integral parts of the pharmaceutical and biotech industries. However, they also present unique operational and strategic challenges. This session will discuss pharmacovigilance implications including adverse event handling and risk mitigation solutions from the regulatory and drug safety point of view. Through case examples, experts will demonstrate how to best utilize these new technologies and procedures in order to meet expectations from regulators and from patients.